Tamminga C A, Carpenter W T
J Nerv Ment Dis. 1982 Dec;170(12):744-51. doi: 10.1097/00005053-198212000-00005.
The classification of schizophrenia-related psychoses under DSM-III into five classes--schizophrenia itself, schizophreniform psychoses, schizoaffective disorders, brief reactive psychoses, and atypical psychoses--classifies groups of psychotic individuals with few distinct pharmacological characteristics. Although ideally established disease entities imply a specific pharmacological regimen, only broad guidelines can be provided in matching an efficacious drug regimen with a diagnostic category. For this reason individualization of pharmacotherapy by each practicing physician is encouraged.
《精神疾病诊断与统计手册》第三版（DSM - III）将与精神分裂症相关的精神病分为五类——精神分裂症本身、分裂样精神病、分裂情感性障碍、急性反应性精神病和非典型精神病——这些类别的精神病个体群体几乎没有明显的药理学特征。虽然理想情况下已确立的疾病实体意味着特定的药物治疗方案，但在将有效的药物治疗方案与诊断类别相匹配时，只能提供宽泛的指导原则。因此，鼓励每位执业医师对药物治疗进行个体化。
